US Broker Ratings

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a Competitive Biotech Landscape with Strategic Potential

For individual investors eyeing opportunities in the biotechnology sector, Fortrea Holdings Inc. (FTRE) presents a compelling case. With a market capitalization of $1.93 billion, Fortrea stands..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 47% Upside in Regenerative Medicine

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, presents a fascinating prospect for investors keen on the healthcare industry. With its..

Zymeworks Inc. (ZYME): Investor Outlook Reveals 50% Upside Potential in Biotech Arena

For investors seeking opportunities within the dynamic biotechnology sector, Zymeworks Inc. (NASDAQ: ZYME) presents a compelling case. With a market capitalization of $1.97 billion, this Delaware-based..

LifeMD, Inc. (LFMD) Stock Analysis: Potential Upside of 153.91% Sparks Investor Interest

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is carving out a niche in the rapidly expanding telehealth industry. Operating primarily in the..

Oculis Holding AG (OCS) Stock Analysis: Unveiling a Potential 254.75% Upside in the Biotech Space

In the ever-evolving world of biotechnology, Swiss-based Oculis Holding AG (NASDAQ: OCS) has emerged as a promising player with significant growth potential. With a market capitalization..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Pioneer with Nearly 100% Upside Potential

Immatics N.V. (IMTX) is making waves in the biotechnology sector, demonstrating a commitment to pioneering therapies in the fight against cancer. With a market capitalization of..

Cronos Group Inc. (CRON) Stock Analysis: A Closer Look at Revenue Growth Amidst Valuation Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, has drawn significant attention from investors due to its remarkable revenue growth and strategic..

Praxis Precision Medicines (PRAX) Stock Analysis: Evaluating a Potential 105.72% Upside in CNS Therapies

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has emerged as a notable player in the biotechnology sector, focusing on developing therapies for central nervous system (CNS) disorders...

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 12% Upside Potential Amidst Healthcare Innovations

InnovAge Holding Corp. (NASDAQ: INNV) is catching the attention of investors with its unique approach to elder care, operating within the expansive healthcare sector. Headquartered in..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating the Healthcare Software Space with a 7.5% Revenue Growth

Simulations Plus, Inc. (NASDAQ: SLP), a renowned player in the healthcare sector, is making waves in the health information services industry with its innovative software solutions..

Neuropace, Inc. (NPCE) Stock Analysis: 43% Potential Upside with Strong Buy Ratings

Neuropace, Inc. (NASDAQ: NPCE) is capturing attention in the healthcare sector, particularly within the medical devices industry, due to its innovative approach in treating drug-resistant focal..

Butterfly Network, Inc. (BFLY) Stock Report: Promising 34% Upside Potential in the Medical Devices Sector

Butterfly Network, Inc. (NYSE: BFLY), a pioneering company in the healthcare sector, is making waves in the medical devices industry with its innovative ultrasound imaging solutions...

Cel-Sci Corporation (CVM) Stock Analysis: Unpacking the 738% Potential Upside

In the dynamic world of biotechnology, Cel-Sci Corporation (CVM) stands out with a remarkable potential upside of nearly 739%, according to current analyst ratings. This intriguing..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 27.74% Upside Potential in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, particularly in the niche of specialty and generic drug manufacturing, is capturing investor..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking a Potential 41% Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector with its pioneering approach to precision medicine. Headquartered in Cambridge, Massachusetts, Relay Therapeutics focuses..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges in the Healthcare Staffing Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a pivotal player in the healthcare staffing sector, providing essential talent management services across the United States. With..

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the Prospects Amid a Challenging Landscape

For investors keeping an eye on the healthcare sector, SIGA Technologies Inc. (NASDAQ: SIGA) presents a compelling case for analysis. Known for its focus on the..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Robust Revenue Growth and Analyst Optimism Signal Potential Upside

Sonida Senior Living, Inc. (SNDA), a notable player in the healthcare sector specializing in medical care facilities, presents a compelling opportunity for investors with its impressive..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Navigating a Complex Landscape in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) presents a fascinating case for investors seeking exposure to the healthcare sector, specifically within the Diagnostics & Research industry. With a..

Kura Oncology, Inc. (KURA) Stock Analysis: A Biotech Innovator with a 173% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) is making waves in the biotechnology sector with its innovative approach to cancer treatment. Based in San Diego, California, this clinical-stage..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds